| Literature DB >> 34063855 |
Giulia Pignataro1, Roberta Di Prinzio1, Paolo Emidio Crisi1, Benedetta Belà1, Isa Fusaro1, Carlo Trevisan2, Luigi De Acetis3, Alessandro Gramenzi1.
Abstract
Dogs with acute diarrhea are often presented to clinical practice and, although this generally represents a self-limiting condition, antibiotics are still frequently used as treatment. The aim of this study was to evaluate the effects in dogs with acute non-hemorrhagic diarrhea of the administration of an antibiotic combination in comparison to a nutraceutical product. Thirty dogs were enrolled and randomly assigned to two groups: 15 dogs (group A) received a nutraceutical commercial product while 15 dogs (group B) received an antimicrobial combination of metronidazole and spiramycin. For each dog, the Canine Acute Diarrhea Severity Index, the fecal microbiota and the Dysbiosis Index were assessed. Both stool consistency and frequency decreased on day 2 in the dogs of group A compared to baseline, while in group B, these parameters significantly decreased at days 3 and 4. The global concern for rising antibiotic resistance associated with indiscriminate use of antimicrobials, in both humans and animals, suggests the necessity of avoiding empirical and injudicious use of these molecules in diarrheic dogs. These results suggest that the nutraceutical treatment had a similar clinical effect compared to the antibiotic formulation, representing a valid antibiotic-sparing therapeutic approach in canine acute diarrhea.Entities:
Keywords: Canine Acute Diarrhea Severity Index; Dysbiosis Index; acute diarrhea; antibiotic-sparing therapy; antimicrobial resistance; dog; gut microbiota; nutraceutical
Year: 2021 PMID: 34063855 DOI: 10.3390/ani11061484
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752